Navigation Links
Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Date:11/19/2007

nual and interim reports filed with the Frankfurt Stock Exchange. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the timing, progress and results of the clinical development, regulatory processes, and commercialization efforts of Nexavar. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2006, filed with the Securities and Exchange Commission under the heading "Risk Factors" and Onyx's Quarterly Reports on Form 10-Q for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward- looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

References

(1) World Health Organization. Hepatitis B. Available at:

http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/.

Accessed April 10, 2007

(2) Penn State Milton S. Hershey Medical Center College of Medicine.

Malignant Hepatoma. Available at:

http://www.hmc.psu.edu/healthinfo/m/malignanthepatoma.htm. Accessed

April 10, 2007.

(3) International
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals,Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
2. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
5. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... -- New device to be showcased at ... medical technology company focused on Navigated Brain Stimulation (NBS), announces ... noninvasive presurgical mapping in clinical neurosurgery. The new device will ... of October 2014, one in Europe ... The new NBS 5 system combines MRI-guided Transcranial ...
(Date:9/17/2014)... Sept. 17, 2014 North America Gynecological ... GlobalData,s new report, "North America ... market data on the North America Gynecological Devices ... US dollars, volume (in units) and average prices ... Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical ...
(Date:9/17/2014)... , Sept. 17, 2014 BRIC ... Summary GlobalData,s new report, "BRIC ... market data on the BRIC Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
Breaking Medicine Technology:Nexstim Launches Next Generation NBS 5 System 2Nexstim Launches Next Generation NBS 5 System 3Nexstim Launches Next Generation NBS 5 System 4Nexstim Launches Next Generation NBS 5 System 5North America Gynecological Devices Market Outlook to 2020 2North America Gynecological Devices Market Outlook to 2020 3BRIC Gynecological Devices Market Outlook to 2020 2BRIC Gynecological Devices Market Outlook to 2020 3
... May 21 BARC, a global,central laboratory today ... trials currently being performed in South Africa by ... vaccine trials are designed to answer scientific questions,that ... safe and effective,vaccine to prevent HIV infection. The ...
... and long-term survivors validate Jennerex ... breakthrough product approach, SAN ... Francisco, CA and Ottawa, Ontario), and its South,Korean partner Green ... its first-in-class lead product JX-594 were published in,the premier journal ...
Cached Medicine Technology:BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials 2BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 2Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 4
(Date:9/18/2014)... 18, 2014 -- BGI Tech Solutions Co., LTD., ... DLF-Trifolium and the Department of Molecular Biology and ... to develop a series of new high-yielding forage ... , GS is a new form of marker ... QTL-based selection, uses information equally from all available ...
(Date:9/18/2014)... VA (PRWEB) September 18, 2014 ... The organization’s first ever digital edition – rich ... the story of how CRDF Global empowers scientists ... diverse network of government, corporate, foundation and individual ... scientists and innovators in research, training and entrepreneurship. ...
(Date:9/18/2014)... September 18, 2014 Research conducted by ... Allegheny Health Network has documented improved survival in ... removal of the tumors along with stereotactic radiosurgery. , ... ASTRO (American Society for Radiation Oncology) this ... numerous precisely focused radiation beams to treat tumors in ...
(Date:9/18/2014)... South Africa (PRWEB) September 18, 2014 ... to adopt the HABIT™ Program in South ... Indaba Health and Wellness, and distributed in South Africa ... of the HABIT program, which has been tailored to ... IHW HABIT™ focuses on behavior modification and chronic disease ...
(Date:9/18/2014)... This past August, Narconon Louisiana New Life Retreat CEO Cathy ... during the West Feliciana Animal Humane Society fundraiser to support the ... my whole life and have always had animals as part of ... a home. Supporting an animal shelter allows me to help ... The CEO of Narconon Louisiana was there not only to lend ...
Breaking Medicine News(10 mins):Health News:BGI Tech, DLF-Trifolium A/S, and Aarhus University applying genomic selection methods 2Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 2Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 3Health News:Narconon New Life Retreat Supports Local Animal Shelter At Recent Fundraiser 2
... its 10th year, the ESMO International Symposium: ... received endorsements from 6 leading professional societies ... Congress as the premier platform for specialists ... clinicians to review the state-of-the-art in gastrointestinal ...
... -- China Sky One,Medical, Inc. (Amex: ... Company"), a China-based,manufacturer, marketer and distributor of ... that its wholly-owned subsidiary,Harbin First Bio-Engineering Pharmaceutical ... development center by the Science and Technology,Institute ...
... Brookdale Senior,Living Inc. (NYSE: BKD ) announced today ... the 2008 Jefferies Healthcare,Conference in New York, New York ... The presentation is being webcast live and can ... website at, http://www.brookdaleliving.com . A replay of the webcast ...
... for ... health plans, WOONSOCKET, R.I., June ... Health Insurance Plans,(AHIP) Institute 2008 to be held June 18-20, 2008 in ... Consumer,Experience" will discuss ways in which health plans can take a proactive,approach ...
... MIAMI and LOS ANGELES, June 19 Cardo ... orthopedic medical devices,and clickNsettle.com, Inc. (OTC Bulletin Board: ... signed a merger agreement pursuant,to which Cardo Medical ... the merger is completed, clickNsettle will be renamed,Cardo ...
... up with Minor League Baseball(TM) to raise awareness of, Benign ... ... U.S., BRIDGEWATER, N.J., June 19 Hall of Fame third,baseman and ... to launch BPH Game Plan Starts with U:,Catch the Whole Game campaign, ...
Cached Medicine News:Health News:10th World Congress on Gastrointestinal Cancer -- Barcelona, Spain 2Health News:China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute 2Health News:China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute 3Health News:CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008 2Health News:CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008 3Health News:clickNsettle.com, Inc. and Cardo Medical, LLC Announce Merger Agreement 2Health News:clickNsettle.com, Inc. and Cardo Medical, LLC Announce Merger Agreement 3Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 2Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 3Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 4Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 5
Aerosolized Medication Device for Infants. An alternative to aerosol blow-by., ,The PediNeb™ was designed to enhance the delivery of aerosolized medication, while reducing the apprehension enc...
... Respiratory Products, ,Westmed designs, manufacturers and ... and Respiratory professionals. Our mission is to ... clinician's ability to deliver quality medical care ... line. , ,Our web site is ...
... ULTRA compressor. This high output compressor can ... medication to the patient's lungs. When combined ... LC STAR® Reusable Nebulizer, the particle size ... retention into the lungs. With less medication ...
... Air., ,Allied Healthcares Timeter® PCS 414 portable ... air compressors that you may wonder if its ... 414 features a durable, mar-resistant steel case thats ... weighs only 26.5 pounds. The PCS 414 has ...
Medicine Products: